Kif2a and HER2 expression in breast cancer tissue chip and their prognostic significance

被引：0
|
作者：
Zhu, Yan [1 ]
Liu, Hong-Bin [1 ]
Yang, Qi-Chang [1 ]
Zhang, Xiao-Juan [1 ]
Shen, Yi [1 ]
Sun, Yong-Qiang [2 ]
机构：
[1] First Peoples Hosp Nantong, Dept Pathol, Nantong, Jiangsu, Peoples R China
[2] First Peoples Hosp Nantong, Dept Surg, Nantong, Jiangsu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2016年 / 9卷 / 08期
关键词：
Kif2a; HER2; tissue chip; breast cancer; immunohistochemistry; prognosis; CENTROMERE-ASSOCIATED KINESIN; OVEREXPRESSION; PROTEIN; CELLS;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Objective: To investigate and evaluate the expression of Kif2a and HER2 in breast cancer tissue chip and their prognostic significance. Methods: The Kif2a and HER2 expression were detected in the cancer and adjacent tissues of 102 patients with breast cancer by tissue chip and immunohistochemistry. The 62 patients were recieved follow-up, and results were analyzed by single factor analysis or Cox regression analysis. Results: There was positive correlation between the expression of Kif2a and HER 2 in breast cancer with different TNM grade and lymph node metastasis (P < 0.05). Kif2a was positively correlated to HER2 (P < 0.01). In the following up of the 62 patients, the results of single factor analysis showed that the survival rate was correlated to the expression of Kif2a and HER2, TNM grade and lymph node metastasis, which was with independently prognostic significance by Cox regression analysis. Conclusion: Kif2a and HER2 expressions in breast cancer tissue were positively correlated to TNM grade and lymph node metastasis (P < 0.05). The expressions of Kif2a and HER2 were with important significance in the detection of potential metastasis of breast cancer and the evaluation of prognosis.
引用
收藏
页码：15394 / 15399
页数：6
相关论文
共 50 条
  • [21] Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
    Park, Ji Soo
    Rha, Sun Young
    Chung, Hyun Cheol
    Jung, Minkyu
    Kim, Ki Hyang
    Jun, Hyun Jung
    Kim, Hyunki
    An, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    ONCOLOGY, 2015, 88 (03) : 147 - 156
  • [22] HER2 as a prognostic factor in breast cancer
    Ménard, S
    Fortis, S
    Castiglioni, F
    Agresti, R
    Balsari, A
    ONCOLOGY, 2001, 61 : 67 - 72
  • [23] Expression of HER2 and its association with AP-2 in breast cancer
    Pellikainen, J
    Naukkarinen, A
    Ropponen, K
    Rummukainen, J
    Kataja, V
    Kellokoski, J
    Eskelinen, M
    Kosma, VM
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) : 1485 - 1495
  • [24] Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
    Loeb, Sanja
    Linsmeier, Eva
    Herbert, Saskia-Laureen
    Schlaiss, Tanja
    Kiesel, Matthias
    Wischhusen, Joerg
    Salmen, Jessica
    Kranke, Peter
    Quenzer, Anne
    Kurz, Florian
    Weiss, Claire
    Gerhard-Hartmann, Elena
    Woeckel, Achim
    Diessner, Joachim
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 5417 - 5428
  • [25] The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma
    Estephan, Fayez
    Banagan, Jeff
    Antonio, Martha
    Liu, Shanshan
    Diao, Guoqing
    Rozalen, Alexandra Zara
    Rajendran, Rithika
    Krasnow, Steven
    Subrahmanyam, Ramesh
    Nava, Victor E.
    Jain, Maneesh
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 67
  • [26] Prognostic significance of HER2 gene amplification according to stage of breast cancer
    Kim, Yong-Seok
    Won, Yong Sung
    Park, Kyung Shin
    Song, Byung Joo
    Kim, Jeong Soo
    Oh, Se Jeong
    Jeon, Hae Myung
    Jung, Sang Seol
    Park, Woo-Chan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (03) : 414 - 420
  • [27] Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer
    Eggemann, Holm
    Ignatov, Tanja
    Burger, Elke
    Kantelhardt, Eva Johanna
    Fettke, Franziska
    Thomssen, Christoph
    Costa, Serban Dan
    Ignatov, Atanas
    ENDOCRINE-RELATED CANCER, 2015, 22 (05) : 725 - 733
  • [28] HER2 Expression in Breast Cancer With Nonamplified HER2 and Gains of Chromosome 17 Centromere
    Panvichian, Ravat
    Tantiwetrueangdet, Anchalee
    Wongwaisayawan, Sansanee
    Nampoon, Amporn
    Lertsithichai, Panuwat
    Leelaudomlipi, Surasak
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (04) : 367 - 374
  • [29] Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
    D Yoshikawa
    H Ojima
    M Iwasaki
    N Hiraoka
    T Kosuge
    S Kasai
    S Hirohashi
    T Shibata
    British Journal of Cancer, 2008, 98 : 418 - 425
  • [30] Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
    Yoshikawa, D.
    Ojima, H.
    Iwasaki, M.
    Hiraoka, N.
    Kosuge, T.
    Kasai, S.
    Hirohashi, S.
    Shibata, T.
    BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 418 - 425
12345